This invention relates to compounds, pharmaceutical compositions, and methods of using compounds of the formula: ##STR1## or a pharmaceutically acceptable salt, hydrate, prodrug, or mixtures thereof, wherein Y is alkylhalo, alkyl-CO--G, COG, a direct bond, C.dbd.O, O, NR.sub.11, or CR.sub.8 ; G is NR.sub.11 R.sub.16, OR.sub.9, SR.sub.9, or R.sub.10 ; Z is O, S, or NR.sub.11 ; X is NR.sub.16, O, S, CR.sub.12 R.sub.13, C.dbd.O, a bond, --CR.sub.12.dbd.CR.sub.13 --, --C(R.sub.12 R.sub.13)C(R.sub.14 R.sub.15)--, or; Rhd 1, R.sub.2, R.sub.3, R.sub.4, R.sub.5, R.sub.6, R.sub.7, R.sub.8, R.sub.10, R.sub.12, R.sub.13, R.sub.14, or R.sub.15 are independently: hydrogen, halo, alkylhalo, hydroxy, C.sub.1 -C.sub.9 straight or branched chain alkyl, C.sub.2 -C.sub.9 straight or branched chain alkenyl group, C.sub.3 -C.sub.8 cycloalkyl, C.sub.5 -C.sub.7 cycloalkenyl, aryl, amino, alkylamino, nitro, nitroso, carboxy, or aralkyl; R.sub.9 is hydrogen, hydroxy, C.sub.1 -C.sub.9 straight or branched chain alkyl, C.sub.2 -C.sub.9 straight or branched chain alkenyl group, C.sub.3 -C.sub.8 cycloalkyl, C.sub.5 -C.sub.7 cycloalkenyl, aryl, amino, alkylamino, carboxy, or aralkyl; R.sub.11 or R.sub.16 are independently: hydrogen, halo, alkylhalo, hydroxy, C.sub.1 -C.sub.9 straight or branched chain alkyl, C.sub.2 -C.sub.9 straight or branched chain alkenyl group, C.sub.3 -C.sub.8 cycloalkyl, C.sub.5 -C.sub.7 cycloalkenyl, aryl, amino, alkylamino, carboxy, or aralkyl.

Esta invenção relaciona-se aos compostos, às composições pharmaceutical, e aos métodos de usar compostos da fórmula: ## do ## STR1 ou um sal, um hydrate, um prodrug, ou umas misturas pharmaceutically aceitáveis disso, wherein Y é alkylhalo, alkyl-CO -- G, COG, uma ligação direta, C.dbd.O, O, NR.sub.11, ou CR.sub.8; G é NR.sub.11 R.sub.16, OR.sub.9, SR.sub.9, ou R.sub.10; Z é O, S, ou NR.sub.11; X são NR.sub.16, O, S, CR.sub.12 R.sub.13, C.dbd.O, uma ligação, -- CR.sub.12.dbd.CR.sub.13 --. -- C(R.sub.12 R.sub.13)C(R.sub.14 R.sub.15) - -, ou; Rhd 1, R.sub.2, R.sub.3, R.sub.4, R.sub.5, R.sub.6, R.sub.7, R.sub.8, R.sub.10, R.sub.12, R.sub.13, R.sub.14, ou R.sub.15 é independentemente: hidrogênio, halo, alkylhalo, hydroxy, C.sub.1 - C.sub.9 em linha reta ou alkyl chain ramificado, C.sub.2 - C.sub.9 em linha reta ou grupo alkenyl chain ramificado, C.sub.3 - C.sub.8 cycloalkyl, C.sub.5 - cycloalkenyl C.sub.7, arilo, amino, alkylamino, nitro, nitroso, carboxy, ou aralkyl; R.sub.9 é hidrogênio, hydroxy, C.sub.1 - C.sub.9 em linha reta ou alkyl chain ramificado, C.sub.2 - C.sub.9 em linha reta ou o grupo alkenyl chain ramificado, C.sub.3 - cycloalkyl C.sub.8, C.sub.5 - cycloalkenyl C.sub.7, arilo, amino, alkylamino, carboxy, ou aralkyl; R.sub.11 ou R.sub.16 são independentemente: hidrogênio, halo, alkylhalo, hydroxy, C.sub.1 - C.sub.9 em linha reta ou alkyl chain ramificado, C.sub.2 - C.sub.9 em linha reta ou grupo alkenyl chain ramificado, C.sub.3 - C.sub.8 cycloalkyl, C.sub.5 - cycloalkenyl C.sub.7, arilo, amino, alkylamino, carboxy, ou aralkyl.

 
Web www.patentalert.com

< (none)

< Phenyl-oxo-tetrahydroquinolin-3-yl beta-3 adrenergic receptor agonists

> Urotensin-II receptor antagonists

> (none)

~ 00059